DAVID EMERSON JORDEN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DAVID EMERSON JORDEN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DAVID EMERSON JORDEN. DAVID EMERSON JORDEN is Director in ConnectOne Bancorp, Inc. ($CNBC) and Director in Nuo Therapeutics, Inc. ($NUOT).
Latest Insider Trading Transactions of DAVID EMERSON JORDEN
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 07 2011 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.34 | 22,500 | 7,740 | 6,227,500 | 6.2 M to 6.2 M (+0.36 %) |
May 20 2011 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.38 | 15,000 | 5,625 | 6,205,000 | 6.2 M to 6.2 M (+0.24 %) |
May 20 2011 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.39 | 22,500 | 8,865 | 6,190,000 | 6.2 M to 6.2 M (+0.36 %) |
May 04 2011 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.36 | 17,500 | 6,300 | 6,167,500 | 6.2 M to 6.2 M (+0.28 %) |
May 03 2011 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.35 | 18,000 | 6,210 | 6,150,000 | 6.1 M to 6.2 M (+0.29 %) |
May 03 2011 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.36 | 33,666 | 12,120 | 6,195,000 | 6.2 M to 6.2 M (+0.55 %) |
May 03 2011 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.33 | 218,334 | 72,050 | 6,161,334 | 5.9 M to 6.2 M (+3.67 %) |
Mar 16 2011 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.38 | 27,500 | 10,368 | 5,875,000 | 5.8 M to 5.9 M (+0.47 %) |
Mar 15 2011 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.40 | 12,500 | 4,938 | 5,847,500 | 5.8 M to 5.8 M (+0.21 %) |
Mar 10 2011 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.40 | 72,200 | 29,169 | 5,765,000 | 5.7 M to 5.8 M (+1.27 %) |
Mar 15 2011 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.39 | 35,000 | 13,755 | 5,835,000 | 5.8 M to 5.8 M (+0.60 %) |
Mar 14 2011 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.40 | 35,000 | 14,000 | 5,800,000 | 5.8 M to 5.8 M (+0.61 %) |
Feb 18 2011 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.44 | 41,586 | 18,131 | 5,606,586 | 5.6 M to 5.6 M (+0.75 %) |
Feb 22 2011 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.43 | 13,414 | 5,768 | 5,620,000 | 5.6 M to 5.6 M (+0.24 %) |
Mar 08 2011 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.41 | 72,800 | 29,484 | 5,692,800 | 5.6 M to 5.7 M (+1.30 %) |
Feb 15 2011 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.42 | 15,000 | 6,300 | 5,565,000 | 5.6 M to 5.6 M (+0.27 %) |
Feb 15 2011 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.44 | 12,450 | 5,478 | 5,550,000 | 5.5 M to 5.6 M (+0.22 %) |
Feb 09 2011 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.45 | 10,000 | 4,500 | 5,510,000 | 5.5 M to 5.5 M (+0.18 %) |
Feb 14 2011 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.44 | 27,550 | 12,205 | 5,537,550 | 5.5 M to 5.5 M (+0.50 %) |
Feb 04 2011 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.45 | 15,000 | 6,750 | 5,500,000 | 5.5 M to 5.5 M (+0.27 %) |
Feb 03 2011 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | J | 0.48 | 20,000 | 9,500 | 5,485,000 | 5.5 M to 5.5 M (+0.37 %) |
Feb 01 2011 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | J | 0.45 | 20,000 | 9,000 | 5,465,000 | 5.4 M to 5.5 M (+0.37 %) |
Jan 28 2011 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | J | 0.46 | 20,000 | 9,200 | 5,445,000 | 5.4 M to 5.4 M (+0.37 %) |
Jan 28 2011 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | J | 0.47 | 22,142 | 10,407 | 5,425,000 | 5.4 M to 5.4 M (+0.41 %) |
Jan 26 2011 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | J | 0.47 | 10,500 | 4,935 | 5,402,858 | 5.4 M to 5.4 M (+0.19 %) |
Jan 26 2011 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | J | 0.00 | 3,358 | 0 | 5,392,358 | 5.4 M to 5.4 M (+0.06 %) |
Jan 25 2011 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.48 | 17,000 | 8,160 | 5,389,000 | 5.4 M to 5.4 M (+0.32 %) |
Jan 24 2011 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.47 | 52,000 | 24,440 | 5,372,000 | 5.3 M to 5.4 M (+0.98 %) |
Mar 09 2011 | CNBC | ConnectOne Bancorp ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.40 | 72,200 | 29,169 | 5,765,000 | 5.7 M to 5.8 M (+1.27 %) |
Dec 22 2010 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.46 | 12,500 | 5,750 | 5,307,500 | 5.3 M to 5.3 M (+0.24 %) |
Dec 28 2010 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.47 | 12,500 | 5,875 | 5,320,000 | 5.3 M to 5.3 M (+0.24 %) |
Dec 21 2010 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.46 | 32,000 | 14,720 | 5,273,000 | 5.2 M to 5.3 M (+0.61 %) |
Dec 22 2010 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.45 | 22,000 | 9,900 | 5,295,000 | 5.3 M to 5.3 M (+0.42 %) |
Dec 17 2010 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.47 | 27,500 | 12,925 | 5,241,500 | 5.2 M to 5.2 M (+0.53 %) |
Dec 17 2010 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.49 | 14,000 | 6,860 | 5,214,000 | 5.2 M to 5.2 M (+0.27 %) |
Dec 15 2010 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.48 | 15,000 | 7,200 | 5,200,000 | 5.2 M to 5.2 M (+0.29 %) |
Dec 14 2010 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.47 | 15,500 | 7,285 | 5,185,000 | 5.2 M to 5.2 M (+0.30 %) |
Dec 10 2010 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.48 | 16,200 | 7,776 | 5,169,500 | 5.2 M to 5.2 M (+0.31 %) |
Dec 08 2010 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.47 | 22,183 | 10,426 | 5,153,300 | 5.1 M to 5.2 M (+0.43 %) |
Dec 07 2010 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.48 | 26,300 | 12,624 | 5,131,117 | 5.1 M to 5.1 M (+0.52 %) |
Dec 07 2010 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.46 | 22,730 | 10,456 | 5,104,817 | 5.1 M to 5.1 M (+0.45 %) |
Dec 06 2010 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.46 | 75,257 | 34,618 | 5,082,087 | 5 M to 5.1 M (+1.50 %) |
Dec 03 2010 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.46 | 37,792 | 17,384 | 5,006,830 | 5 M to 5 M (+0.76 %) |
Dec 02 2010 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.46 | 45,000 | 20,700 | 4,969,038 | 4.9 M to 5 M (+0.91 %) |
Dec 01 2010 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.46 | 45,650 | 20,999 | 4,924,038 | 4.9 M to 4.9 M (+0.94 %) |
Nov 30 2010 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.45 | 50,100 | 22,545 | 4,878,388 | 4.8 M to 4.9 M (+1.04 %) |
Nov 26 2010 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.46 | 12,500 | 5,750 | 4,828,288 | 4.8 M to 4.8 M (+0.26 %) |
Nov 24 2010 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.46 | 25,288 | 11,632 | 4,815,788 | 4.8 M to 4.8 M (+0.53 %) |
Nov 23 2010 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.48 | 15,000 | 7,200 | 4,790,500 | 4.8 M to 4.8 M (+0.31 %) |
Nov 22 2010 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.49 | 5,000 | 2,450 | 4,775,500 | 4.8 M to 4.8 M (+0.10 %) |
Nov 19 2010 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.50 | 7,500 | 3,750 | 4,770,500 | 4.8 M to 4.8 M (+0.16 %) |
Nov 17 2010 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.49 | 9,969 | 4,885 | 4,763,000 | 4.8 M to 4.8 M (+0.21 %) |
Nov 09 2010 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.50 | 7,500 | 3,750 | 4,742,500 | 4.7 M to 4.7 M (+0.16 %) |
Page: 1